Nouscom United Kingdom United States of America Switzerland

Nouscom Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate NOUS-209 in combination with KEYTRUDA® in a Phase 2 Randomized Trials in dMMR/MSI-High Metastatic Colorectal Cancer

or follow us on LinkedIn

Contacts:

Nouscom
Richard Davis, COO
E: [e-mail]
T: [phone]

MEDiSTRAVA Consulting
Sylvie Berrebi, Eleanor Perkin
E: [e-mail]
T: [phone]

 

View original content:https://www.prnewswire.co.uk/news-releases/nouscom-announces-clinical-trial-collaboration-and-supply-agreement--with-msd-to-evaluate-nous-209-in-combination-with-keytruda-pembrolizumab-in-a-phase-2-randomized-trials-in-dmmrmsi-high-metastatic-colorectal-cancer-301714118.html